期刊文献+

白血病患者化疗后合并化脓性髋关节炎2例及文献复习

Leukemia patients complicated with suppurative hip arthritis after chemotherapy:two cases report and literature review
下载PDF
导出
摘要 粒细胞缺乏感染是血液恶性肿瘤患者化疗后的一种严重并发症,其进展迅速,可能导致危及生命的并发症。其中少见部位的感染,由于诊断困难,经常出现误诊、漏诊等情况。目前正常人群中化脓性髋关节炎案例较少,而白血病化疗后合并化脓性髋关节炎更为罕见,相关报道极少。本研究介绍了2例因白血病入院化疗后出现发热伴关节疼痛患者的诊疗经过,持续关注其体温及感染指标的变化、抗感染方案的改变,最终通过病理证实为化脓性髋关节炎。同时通过对相关文献进行复习总结,以期提高临床对粒细胞缺乏期罕见部位感染的识别和诊疗的认识。 Agranulocytosis infection is a serious complication after chemotherapy in patients with hematological malignancies,which progresses rapidly and may lead to life-threatening complications.Due to the difficulty in diagnosis,the infection in rare sites is often misdiagnosed and missed diagnosed.At present,there are few cases of pyogenic hip arthritis in normal population,and suppurative hip arthritis after chemotherapy of leukemia is even rarer,and there are few relevant reports.This study introduces the 2 cases admitted to hospital because of leukemia after chemotherapy fever with joint pain in patients with diagnosis and treatment,continuous attention to the body temperature and infection index changes,the change of plan to fight infection,ultimately through pathology confirmed for suppurative hip arthritis.At the same time,the relevant literature was reviewed in order to improve the clinical recognition,diagnosis and treatment of rare site infection in the agranulocytosis stage.
作者 芮婧雯 周必琪 李沛城 徐杨 Rui Jingwen;Zhou Biqi;Li Peicheng;Xu Yang(Department of Hematology,the First Affiliated Hospital of Soochow University,National Clinical Medical Research Center for Hematology Diseases,Jiangsu Institute of Hematology,Key Laboratory of Thrombosis and Hemostasis of the Ministry of Health,Soochow University Institute of Hematopoietic Stem Cell Transplantation,Suzhou 215006,China;Department of Interventional,the First Affiliated Hospital of Soochow University,Suzhou 215006,China)
出处 《中国医药》 2024年第3期460-463,共4页 China Medicine
基金 国家重点研发计划(2022YFC2502704)。
关键词 白血病 化脓性髋关节炎 感染 Leukemia Suppurative hip arthritis Infection
  • 相关文献

参考文献8

二级参考文献88

  • 1樊寻梅,武志远.国际儿科脓毒症定义会议介绍[J].中华儿科杂志,2005,43(8):618-620. 被引量:90
  • 2胡凤华,甘小庄,孙丽萍,郭琳英,李杰,任晓旭,崔小岱,宋国维.脓毒症患儿降钙素原测定的临床意义[J].实用儿科临床杂志,2007,22(6):412-413. 被引量:15
  • 3韩冰,邸海侠,周道斌,赵永强,王书杰,许莹,陈嘉林,段云,焦力,段明辉,张薇,朱铁楠,邹农,沈悌.血液科2388例次住院患者感染危险因素的分析[J].北京医学,2007,29(6):327-329. 被引量:21
  • 4Muller B, Harbarth S, Stolz D, et al. Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia. BMC Infect Dis, 2007, 7 (1): 10.
  • 5Schuetz P, Albrich W, Mueller B. Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future. BMC Medicine, 2011, 9( 1) : 107.
  • 6Nobre V, Harbarth S, Graf JD, et al. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Hespir Crit Care Med, 2008, 177(5): 498-505.
  • 7Bouadma L, Luyt CE, Tubach F, et al. PRORATA trial group: Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet, 2010, 375 (9713): 463474.
  • 8Christ-Crain M, Stolz D, Bingisser R. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med, 2006, 174(1) : 84-93.
  • 9Christ-Crain M, Jaccard-Stolz D, Bingisser R, et al. Effect of procalcitonin -guided treatment on antibiotic use and outcome in lower respiratory tract infections: clusterrandomised, singleblinded intervention trial. Lancet, 2004, 363(9409): 600-607.
  • 10Long W, Deng X, Zhang Y, et al. Procalcitonin-guidance for reduction of antibiotic use in low-risk outpatients with community acquired pneumonia. Respirology, 2011, 16( 5) : 819-824.

共引文献226

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部